Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
29681-21-8
31290-76-3
53609-62-4
102867-56-1
52788-79-1
77078-22-9
236750-65-5 | 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile | AA002O1J | MFCD17676647
2451-01-6 | Cis-p-menthane-1,8-diol monohydrate | AA002OAY | MFCD00083415
246029-02-7 | 5-Fluorobenzofuran-7-ol | AA002ONF | MFCD07368089
24676-83-3 | 2,5-Piperazinedione, 3-methyl-6-(2-methylpropyl)-, (3S,6S)- | AA002OXN | MFCD00079086
247573-71-3 | 2-(Benzyloxy)-5-(trifluoromethyl)pyridine | AA002P8X | MFCD02948742
24855-58-1 | 4-Hydroxy-3-nitrobenzenesulfonamide | AA002PKQ | MFCD00129906
2493-02-9 | Benzene, 1-bromo-4-isocyanato- | AA002PUK | MFCD00002022
25044-10-4 | Pentanoic acid, 4-methyl-2-methylene- | AA002Q6K | MFCD00797959
25141-45-1 | Acetic acid, 2-[2-(phenylmethyl)phenoxy]- | AA002QJ1 | MFCD03152536
25199-00-2 | 4-Chloro-5-propylpyrimidine | AA002QSF | MFCD09971219